A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis - ScienceDirect

Human‐based systems: Mechanistic NASH modelling just around the corner?

Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening

Anti Human CD163 Antibody, clone EDHu-1

PDF] Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

MASH CALL for Fast and Reliable Identification and Comparison of Drug Candidates - InSphero

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis - ScienceDirect

Human‐based systems: Mechanistic NASH modelling just around the corner?